Regeneron Pharmaceuticals (REGN) Amortization of Deferred Charges (2012 - 2013)

Regeneron Pharmaceuticals (REGN) posted quarterly Amortization of Deferred Charges of $5.7 million for Q4 2013, down 2.89% year-over-year from $5.9 million in Q4 2012, and down 4.27% quarter-over-quarter from $6.0 million in Q3 2013.

Regeneron Pharmaceuticals (REGN) Amortization of Deferred Charges (2012 - 2013) Analysis & Trends

Regeneron Pharmaceuticals' Amortization of Deferred Charges history runs 2 years deep, the most recent figure standing at $5.7 million for Q4 2013.

  • In Q4 2013, Amortization of Deferred Charges fell 2.89% year-over-year to $5.7 million; the TTM figure through Dec 2013 stood at $23.1 million (up 0.59% YoY), while the FY2013 annual figure was $23.1 million, up 0.59% from the prior year.
  • Amortization of Deferred Charges for Q4 2013 stood at $5.7 million, down from $6.0 million in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $6.0 million in Q3 2013, with the low at $5.5 million in Q2 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 5.75 Mn
Dec 31, 2013 5.75 Mn
Sep 30, 2013 6.00 Mn
Sep 30, 2013 6.00 Mn
Jun 30, 2013 5.53 Mn
Jun 30, 2013 5.53 Mn
Mar 31, 2013 5.78 Mn
Mar 31, 2013 5.78 Mn
Dec 31, 2012 5.92 Mn
Dec 31, 2012 5.92 Mn
Sep 30, 2012 5.82 Mn
Sep 30, 2012 5.82 Mn
Jun 30, 2012 5.65 Mn
Jun 30, 2012 5.65 Mn
Mar 31, 2012 5.54 Mn
Mar 31, 2012 5.54 Mn